Aurobindo Pharma USA Inc. recalls Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only,
Aurobindo Pharma recalls 500-tablet bottles of Sulfamethoxazole and Trimethoprim Tablets (800 mg/160 mg) due to metal wire complaints. This could cause injury if swallowed. Contact for return instructions.
Lower-risk recall
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Contact the company & request your remedy
What happened, in plain English
Aurobindo Pharma is recalling 500-tablet bottles of Sulfamethoxazole and Trimethoprim Tablets (800 mg/160 mg) because metal wire was found in some tablets. This could cause injury if swallowed, so affected users should stop using the product and contact the company for a refund. Read more at govinfonow.com/recall/36847-aurobindo-pharma-sulfamethoxazole-trimethoprim-tablets-recall-metal-wire-in-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/36847-aurobindo-pharma-sulfamethoxazole-trimethoprim-tablets-recall-metal-wire-in-tablets · Updated October 5, 2026 · FDA enforcement record: FDA #D-1535-2020
Cite this page
“Aurobindo Pharma Sulfamethoxazole/Trimethoprim Tablets Recall: Metal Wire in Tablets.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36847-aurobindo-pharma-sulfamethoxazole-trimethoprim-tablets-recall-metal-wire-in-tablets. Based on FDA recall #D-1535-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1535-2020%22&limit=1).
Why it’s dangerous
Metal wire can be present in the tablets, which may cause injury if swallowed. This is a foreign substance that could lead to internal damage or choking.
Who’s affected
Prescription users of Sulfamethoxazole and Trimethoprim Tablets (800 mg/160 mg) who received the recalled bottles. People with specific medical conditions requiring this medication are most at risk.
How to tell if you have this one
Check for bottles labeled 'Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only'. The lot numbers STSD19109-A (expiring 05/31/2022) and SP1D19083AA3/SP1D19084AA3 (expiring 08/31/2022) are affected.
- Brand
Aurobindo Pharma- Category
Drug
What to do — step by step
Stop Using Now
Discard the recalled tablets immediately to avoid potential injury from metal wire.
Questions people ask
Is this product safe to use?
No, the product contains metal wire which could cause injury if swallowed. Do not use the recalled tablets.
How can I check if I have the recalled product?
Check for bottles labeled 'Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only' with lot numbers STSD19109-A (expiring 05/31/2022) or SP1D19083AA3/SP1D19084AA3 (expiring 08/31/2022).
What should I do if I have the recalled product?
Discard the tablets immediately and contact Aurobindo Pharma USA Inc for a refund or replacement.
Contact Aurobindo Pharma
We’ve drafted a message you can send Aurobindo Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-1535-2020 — Aurobindo Pharma Aurobindo Pharma Hello, I own a Aurobindo Pharma that is covered by recall D-1535-2020 from Aurobindo Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1535-2020 (August 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1535-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.